OBJECTIVES: Our objective in this study was to evaluate Tpeak-Tend interval (Tp-e) and other electrocardiographic parameters as risk factors for recurrence of life-threatening cardiac events in patients with the Brugada syndrome (BS). BACKGROUND: The Tp-e interval in the electrocardiogram (ECG) has been reported to predict life-threatening arrhythmias in the long QT syndrome. METHODS: Twenty-nine patients with the ECG pattern of BS and 29 healthy age- and gender-matched controls were studied. The follow-up period was 42.65 +/- 24.42 months (range 11 to 108 months). RESULTS: Upon presentation, five patients had suffered aborted sudden death, five syncope, and two presyncope. Eleven patients with the ECG pattern of BS had a prolonged (>460 ms) QTc in V2 but usually not in inferior or left leads. No patient had abnormally prolonged QT dispersion. Programmed electrical stimulation induced ventricular tachycardia/fibrillation in 5 out of 26 patients. Inducibility did not predict recurrence of events. Cardioverter-defibrillators were implanted in 14 patients (all symptomatic and two asymptomatic). During follow-up, nine symptomatic patients experienced recurrences. Previous cardiac events and a QTc >460 ms in V2 were significant risk factors (p = 0.00002 and p = 0.03, respectively). Tp-e and Tp-e dispersion were significantly prolonged in patients with recurrences versus patients without events (104.4 and 35.6 ms vs. 87.4 and 23.2 ms; p = 0.006 and p = 0.03, respectively) or controls (90.7 and 17.9 ms; p = 0.02 and p = 0.001, respectively). CONCLUSIONS: Our study demonstrates significant correlation between previous events, QTc >460 ms in V2, Tp-e, and Tp-e dispersion and occurrence of life-threatening arrhythmic events, suggesting that these parameters may be useful in risk stratification of patients with the Brugada syndrome.
OBJECTIVES: Our objective in this study was to evaluate Tpeak-Tend interval (Tp-e) and other electrocardiographic parameters as risk factors for recurrence of life-threatening cardiac events in patients with the Brugada syndrome (BS). BACKGROUND: The Tp-e interval in the electrocardiogram (ECG) has been reported to predict life-threatening arrhythmias in the long QT syndrome. METHODS: Twenty-nine patients with the ECG pattern of BS and 29 healthy age- and gender-matched controls were studied. The follow-up period was 42.65 +/- 24.42 months (range 11 to 108 months). RESULTS: Upon presentation, five patients had suffered aborted sudden death, five syncope, and two presyncope. Eleven patients with the ECG pattern of BS had a prolonged (>460 ms) QTc in V2 but usually not in inferior or left leads. No patient had abnormally prolonged QT dispersion. Programmed electrical stimulation induced ventricular tachycardia/fibrillation in 5 out of 26 patients. Inducibility did not predict recurrence of events. Cardioverter-defibrillators were implanted in 14 patients (all symptomatic and two asymptomatic). During follow-up, nine symptomatic patients experienced recurrences. Previous cardiac events and a QTc >460 ms in V2 were significant risk factors (p = 0.00002 and p = 0.03, respectively). Tp-e and Tp-e dispersion were significantly prolonged in patients with recurrences versus patients without events (104.4 and 35.6 ms vs. 87.4 and 23.2 ms; p = 0.006 and p = 0.03, respectively) or controls (90.7 and 17.9 ms; p = 0.02 and p = 0.001, respectively). CONCLUSIONS: Our study demonstrates significant correlation between previous events, QTc >460 ms in V2, Tp-e, and Tp-e dispersion and occurrence of life-threatening arrhythmic events, suggesting that these parameters may be useful in risk stratification of patients with the Brugada syndrome.
Authors: Arthur A M Wilde; Charles Antzelevitch; Martin Borggrefe; Josep Brugada; Ramón Brugada; Pedro Brugada; Domenico Corrado; Richard N W Hauer; Robert S Kass; Koonlawee Nademanee; Silvia G Priori; Jeffrey A Towbin Journal: Circulation Date: 2002-11-05 Impact factor: 29.690
Authors: Maria Vittoria Pitzalis; Matteo Anaclerio; Massimo Iacoviello; Cinzia Forleo; Pietro Guida; Rossella Troccoli; Francesco Massari; Filippo Mastropasqua; Sandro Sorrentino; Andrea Manghisi; Paolo Rizzon Journal: J Am Coll Cardiol Date: 2003-11-05 Impact factor: 24.094
Authors: Charles Antzelevitch; Pedro Brugada; Josep Brugada; Ramon Brugada; Jeffrey A Towbin; Kolawanee Nademanee Journal: J Am Coll Cardiol Date: 2003-05-21 Impact factor: 24.094
Authors: C Antzelevitch; P Brugada; J Brugada; R Brugada; W Shimizu; I Gussak; A R Perez Riera Journal: Circ Res Date: 2002-12-13 Impact factor: 17.367
Authors: Augustus O Grant; Michael P Carboni; Valentina Neplioueva; C Frank Starmer; Mirella Memmi; Carlo Napolitano; Silvia Priori Journal: J Clin Invest Date: 2002-10 Impact factor: 14.808
Authors: Annabella Braschi; Vincenzo C Francavilla; Maurizio G Abrignani; Lorenzo Todaro; Giuseppe Francavilla Journal: Ann Noninvasive Electrocardiol Date: 2012-04 Impact factor: 1.468
Authors: Tanveer A Bhuiyan; Claus Graff; Jørgen K Kanters; Jimmi Nielsen; Jacob Melgaard; Jørgen Matz; Egon Toft; Johannes J Struijk Journal: Clin Drug Investig Date: 2015-11 Impact factor: 2.859
Authors: Charles Antzelevitch; Serge Sicouri; José M Di Diego; Alexander Burashnikov; Sami Viskin; Wataru Shimizu; Gan-Xin Yan; Peter Kowey; Li Zhang Journal: Heart Rhythm Date: 2007-06-08 Impact factor: 6.343
Authors: Gunnar Erikssen; Knut Liestøl; Lars Gullestad; Kristina H Haugaa; Bjørn Bendz; Jan P Amlie Journal: Ann Noninvasive Electrocardiol Date: 2012-04 Impact factor: 1.468
Authors: Pentti M Rautaharju; Zhu-ming Zhang; Richard E Gregg; Wesley K Haisty; Mara Z Vitolins; Anne B Curtis; James Warren; Milan B Horaĉek; Sophia H Zhou; Elsayed Z Soliman Journal: J Electrocardiol Date: 2013-07-01 Impact factor: 1.438
Authors: Hakan Taşolar; Mehmet Ballı; Mustafa Çetin; Yılmaz Ömür Otlu; Burak Altun; Adil Bayramoğlu Journal: Ann Noninvasive Electrocardiol Date: 2014-06-16 Impact factor: 1.468